Search Within

Hematologic Malignancies, Division of

Formats
  1. Meeting Abstract (6372)
  2. Journal Article (5780)
  3. Review (420)
  4. Editorial (194)
  5. Book Section (188)
  6. Research Letter (179)
  7. Guidelines (88)
  8. Conference Paper (65)
  9. Correspondence (62)
  10. Miscellaneous (18)
  11. Book Whole (9)
Groups
  1. Department of Medicine (13274)
  2. Center for Hematologic Malignancies (10609)
  3. GSK Faculty (4481)
  4. Adult Leukemia (3672)
  5. Bone Marrow Transplant (2848)
  6. Lymphoma (2704)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (943)
  3. Ross Levine (787)
  4. Andrew Zelenetz (784)
  5. Steven Horwitz (669)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (336)
  2. 2024 (823)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3529)
  2. Journal of Clinical Oncology (1233)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (329)
  5. Haematologica (291)
  6. Bone Marrow Transplantation (239)

More Publications

Publishers
  1. American Society of Hematology (3806)
  2. Elsevier Inc. (1529)
  3. American Society of Clinical Oncology (1288)
  4. Nature Publishing Group (1009)
  5. American Association for Cancer Research (641)
  6. Wiley Blackwell (433)

More Publishers

Results (13375)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Understanding genomic and social determinants of cancer immunotherapy outcome across ancestry
    Meeting Abstract

    Fong, C. J.; Waters, M.; Pichotta, K.; Jee, J.; Jutagir, D. R.; Ma, D.; Perea-Chamblee, T.; Kim, S.; Arora, K.; Mastrogiacomo, B.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • A comparison of the prognostic performance of the Lugano 2014 and RECIL 2017 response criteria in patients with NHL from the phase III GOYA and GALLIUM trials
    Journal Article

    Kostakoglu, L.; Martelli, M.; Sehn, L. H.; Davies, A.; Trneny, M.; Herold, M.; Vitolo, U.; Hiddemann, W.; Trotman, J.; Knapp, A.; more...
    eJHaem (2023)

    Fulltext@MSK | Save
  • Treatment outcomes and prognostic factors with lenalidomide, bortezomib, and dexamethasone (RVd) alone versus RVd plus autologous stem cell transplantation (ASCT) in African American (AA) patients (pts) with newly diagnosed multiple myeloma (NDMM) in the DETERMINATION phase 3 trial
    Meeting Abstract

    Houde, C. A.; Khan, A.; Jacobus, S. J.; Hassoun, H.; Anderson, L. D. Jr; Merz, L. E.; Zon, R. L.; Efebera, Y.; Buck, T.; Innis-Shelton, R. D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Practice patterns of transplant centers regarding maintenance treatment post allogeneic hematopoietic cell transplantation in acute myeloid leukemia: A survey on behalf of the EBMT Acute Leukemia Working Party
    Meeting Abstract

    Abou Dalle, I.; Labopin, M.; Khvedelidze, I.; Baron, F.; Brissot, E.; Bug, G.; Esteve, J.; Giebel, S.; Gorin, N. C.; Lanza, F.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes of patients with accelerated/blast-phase MPNs that received allogeneic stem-cell transplant in the current era of myeloid therapies
    Meeting Abstract

    Patel, A. A.; Yoon, J. J.; Johnston, H.; Davidson, M. B.; Viswabandya, A.; Shallis, R. M.; Chen, E. C.; Burkart, M.; Oh, T. S.; Iyer, S. G.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in relapsed/refractory follicular lymphoma: Results from the phase 1/2 BRUIN study
    Meeting Abstract

    Shah, N. N.; Zinzani, P. L.; Wang, M. L.; Nasta, S. D.; Lech-Maranda, E.; Ogawa, Y.; Fakhri, B.; Kuss, B.; Miyashita, K.; Patel, K.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Sustained efficacy and safety with asciminib (ASC) after almost 4 years of median follow-up from ASCEMBL, a phase 3 study of ASC vs bosutinib (BOS) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) after ≥2 prior tyrosine kinase inhibitors (TKIs): An end of study treatment (EOS Tx) update, including results from switch population
    Meeting Abstract

    Mauro, M.; Minami, Y.; Hochhaus, A.; Lomaia, E.; Voloshin, S.; Turkina, A.; Kim, D. W.; Apperley, J. F.; Cortes, J.; Abdo, A. N. R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • CNS prophylaxis in adult ALL patients after stem cell transplantation: An EBMT survey on general practice
    Meeting Abstract

    Chiusolo, P.; Labopin, M.; Khvedelidze, I.; Baron, F.; Brissot, E.; Bazarbachi, A.; Bug, G.; Esteve, J.; Giebel, S.; Gorin, N. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • PET4 response as an independent predictor of long-term outcomes in ECHELON2 (A+CHP vs. CHOP) in CD30+PTCL
    Meeting Abstract

    Iyer, S. P.; Mehta-Shah, N.; Advani, R. H.; Bartlett, N. L.; Christensen, J. H.; Morschhauser, F.; Domenech, E. D.; Pagani, C.; Kim, W. S.; Alpdogan, O.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Hepatic response and progression criteria in light chain amyloidosis: A multicenter validation study
    Meeting Abstract

    Muchtar, E.; Palladini, G.; Schonland, S.; Dispenzieri, A.; Wisniowski, B.; Merlini, G.; Milani, P.; Hegenbart, U.; Dittrich, T.; Kastritis, E.; more...
    Blood (2023)

    Fulltext@MSK | Save